New Mexico Enacts Medical Psilocybin Act
1 min read
Written By
Kelly Uebel
Published
Jul 01, 2025
New Mexico recently passed Senate Bill 219, the Medical Psilocybin Act, which is now in effect.
According to the New Mexico Department of Health, the “legislation establishes a regulated program for the medical use of psilocybin, a naturally occurring psychedelic compound, to treat qualified medical conditions such as major treatment-resistant depression, PTSD, substance use disorders, and end-of-life care.”
The Department expects the program to be fully implemented by December 31, 2027. The Department is now working on developing the rules and regulations that will govern the program. At this time, there are no requirements for employers to accommodate psilocybin use while at work.
Employers should continue to track any new rules and regulations the New Mexico Department of Health may release to determine if any changes to their drug testing or workplace drug policies may be required in the future.
You might also like
The New Renter Mindset: What Applicants Expect from Tenant Screening Today
Uncover key expectations renters bring into the screening process today and what those expectations mean for Property Operations teams.
Why Healthcare Background Screening Needs to Change: A Conversation with Verisys and Asurint
Verisys and Asurint leaders walk through what's actually working in healthcare background screening, what's being missed, and where traditional approaches are starting to fall short.
Virginia’s Clean Slate Act Takes Effect July 1, 2026
Beginning July 1, 2026, Virginia's Clean Slate Act will significantly expand record sealing. What does this mean for consumer reporting agencies providing background checks?